View of AI-DRIVEN DRUG TARGET IDENTIFICATION IN NEURODEGENERATION: APPLICATIONS IN ALZHEIMER'S, PARKINSON'S, AND ALS RESEARCH | Global Conference on Medical and Health Sciences